European Commission approves yuvanci for pulmonary arterial hypertension treatment
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan...
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan...
WASHINGTON, Oct. 1, 2src24 – Today, the U.S. Department of Agriculture (USDA) released the following statement in response to labor disputes at...
Tuesday 1 October, 2024 Glass Pharms and the Advanced Plant Growth Centre at The James Hutton Institute are to conduct...
More than one-third of adults in the United States have metabolic syndrome, a cluster of conditions that significantly raise a...